BRIEF published on 02/03/2026 at 12:17, 7 months 18 days ago GeNeuro SA bankrupt after the end of the composition moratorium Biopharmaceutical Bankruptcy GeNeuro Geneva Court Concordat Moratorium
BRIEF published on 02/03/2026 at 12:14, 7 months 18 days ago GeNeuro SA Declares Bankruptcy Following Debt Moratorium Biopharmaceutical Bankruptcy Court Ruling GeNeuro SA Debt Moratorium
PRESS RELEASE published on 02/03/2026 at 12:09, 7 months 18 days ago INSIDE INFORMATION / OTHER NEWS RELEASES GeNeuro SA announces the end of debt moratorium and commencement of bankruptcy proceedings after Geneva Court ruling. Further details in official publications Biopharmaceutical Company GeNeuro SA Bankruptcy Proceedings Debt Moratorium Geneva Court Ruling
BRIEF published on 01/23/2026 at 11:05, 7 months 29 days ago GeNeuro SA Suspends Trading Ahead of Court Ruling Euronext Paris Trading Suspension GeNeuro Debt Moratorium Geneva Court
BRIEF published on 01/23/2026 at 11:05, 7 months 29 days ago Temporary suspension of trading of GeNeuro SA shares on Euronext Paris Restructuring GeNeuro SA Geneva Court Trading Suspended Concordat Moratorium
PRESS RELEASE published on 01/23/2026 at 11:00, 7 months 29 days ago Inside Information / Other news releases GeNeuro SA requests temporary suspension of trading on Euronext Paris pending Geneva Court judgment on debt moratorium. Details on debt restructuring and impact on operations Euronext Paris GeNeuro SA Swiss Law Temporary Suspension Debt Moratorium
BRIEF published on 10/15/2025 at 20:30, 11 months 6 days ago GeNeuro Delays Half-Year Financial Report Release Financial Report Restructuring Biopharmaceutical GeNeuro Debt Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 11 months 6 days ago Inside Information / Other news releases GeNeuro SA postpones the publication of June 30, 2025 half-yearly financial report to assess financial impacts of debt-restructuring moratorium extension. New date to be announced Financial Report Postponement Neurological Disorders GeNeuro SA Debt-restructuring Moratorium
BRIEF published on 09/26/2025 at 18:41, 11 months 25 days ago GeNeuro SA: Extension of the debt restructuring stay until 2026 Restructuring GeNeuro Neurological Diseases Composition Stay Geneva Court
PRESS RELEASE published on 09/26/2025 at 18:36, 11 months 25 days ago Inside Information / Other news releases GeNeuro SA extends its definitive debt-restructuring moratorium until January 27, 2026, to explore strategic options and continue developing treatments for neurodegenerative and autoimmune diseases Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Moratorium
Published on 09/21/2026 at 15:45, 5 hours 10 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 6 hours 35 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 6 hours 50 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 6 hours 55 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 7 hours 10 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 20:34, 20 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 18:00, 2 hours 55 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 3 hours 10 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 3 hours 10 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 3 hours 55 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 2 hours 36 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 2 hours 53 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 3 hours 9 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 07:00, 13 hours 55 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
